Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-23

Clinical Trial Update: Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis [Phase 3]

View source ↗

Summary

A Phase 3 trial compared six weeks versus two weeks of doxycycline treatment for Lyme neuroborreliosis; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: Sorlandet Hospital HF | Conditions: Neuroborreliosis, Borrelia Burgdorferi | Phase 3 | Status: COMPLETED | Results posted: 2024-01-23